Author:
Abida ,Imran Mohd,Eltaib Lina,Ali Akbar,Alanazi Razan Abdulaziz Salem,Singla Neelam,Asdaq Syed Mohammed Basheeruddin,Al-Hajeili Marwan,Alhakami Fatemah Abdulaziz,Al-Abdulhadi Saleh,Abdulkhaliq Altaf A.,Rabaan Ali A.
Funder
Northern Borders University
Reference158 articles.
1. Gut microbiota and depressive symptoms at the end of CRT for rectal cancer: a cross-sectional pilot study;Gonzalez-Mercado;Depress Res. Treat.,2021
2. Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China;Wang;Int. J. Colorectal Dis.,2021
3. Hits and misses in novel pancreatic and rectal cancer treatment options;Chuong;Int. J. Radiat. Oncol. Biol. Phys.,2023
4. M. Okada, K. Kawai, K. Sasaki, H. Nozawa, M. Kaneko, K. Murono, S. Emoto, Y. Iida, H. Ishii, Y. Yokoyama, H. Anzai, H. Sonoda, S. Ishihara, Intervention Strategies to Reduce Surgical Site Infection Rates in Patients Undergoing Rectal Cancer Surgery, In vivo (Athens, Greece), 36 (2022) 439-445.
5. Rectal ischemia causes mass formation, masquerading as rectal cancer;Fousekis;Oxf. Med. Case Rep.,2018